Home Cart Sign in  
Chemical Structure| 132819-92-2 Chemical Structure| 132819-92-2

Structure of NOD-IN-1
CAS No.: 132819-92-2

Chemical Structure| 132819-92-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

NOD-IN-1 is a potent mixed inhibitor of nucleotide-binding oligomerization domain (NOD)-like receptors, NOD1 and NOD2, with IC50 of 5.74 μM and 6.45 μM, respectively.

Synonyms: MDK19922

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of NOD-IN-1

CAS No. :132819-92-2
Formula : C18H17NO4S
M.W : 343.40
SMILES Code : O=C(C(N1S(=O)(C2=CC=C(C)C=C2)=O)=CC3=C1C=CC=C3)OCC
Synonyms :
MDK19922
MDL No. :MFCD30496705
InChI Key :OJMOGUKIYRAILM-UHFFFAOYSA-N
Pubchem ID :14783456

Safety of NOD-IN-1

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
RAW264.7 murine macrophages 10 μM 24 h NOD-IN-1 significantly inhibited P. intermedia LPS-induced Tnf-α mRNA expression and increased P. intermedia LPS-induced Il-6 mRNA expression. Front Microbiol. 2022 Dec 8;13:1049525.
ANA-1 macrophages 50 µg/ml 12 h To investigate the effect of NOD-IN-1 on histone H3-induced pyroptosis, results showed that NOD-IN-1 suppressed NOD2 expression and upregulated VSIG4 expression. Front Cell Infect Microbiol. 2020 May 5;10:196.
RAW 264.7 cells 25 µM 12 h NOD-IN-1 significantly attenuated the colocalization between M. ovipneumoniae and LC3, indicating that NOD2 plays a crucial role in M. ovipneumoniae-induced autophagy J Bacteriol. 2020 Sep 23;202(20):e00689-19.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice P. intermedia LPS-induced periodontitis model Intraperitoneal injection 5 mg/μL Every 48 hours for 26 days NOD-IN-1 reduced P. intermedia LPS-induced periodontal inflammation by intraperitoneal injection, decreasing TNF-α and IL-6 expression. Front Microbiol. 2022 Dec 8;13:1049525.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.91mL

0.58mL

0.29mL

14.56mL

2.91mL

1.46mL

29.12mL

5.82mL

2.91mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories